2017-2022 Global Top Countries Radiopharmaceutical Market Report

Publisher Name :
Date: 13-Sep-2017
No. of pages: 151
Price : Single User: US $ 4960  US $ 4365 Corporate User: US $ 9920  US $ 8432
This report is available at 12% Discount for Single User License and 15% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

"This report will be delivered in 2-3 business days after the order is placed."

The Global Radiopharmaceutical market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.

This report studies Radiopharmaceutical in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Manufacturers in each country, covering

- Bayer

- Triad Isotopes

- Lantheus

- GE Healthcare

- Mallinckrodt

- Eli Lilly

- Bracco Imaging

- SIEMENS

- Navidea

- Nordion

- IBA Group

- Jubilant Pharma

Market Segment by Countries, this report splits Global into several key Countries, with sales, revenue, market share of top 5 players in these Countries, from 2012 to 2017 (forecast), like

- United States

- Canada

- Mexico

- Germany

- France

- UK

- Italy

- Russia

- China

- Japan

- India

- Korea

- Southeast Asia

- Australia

- Brazil

- Middle East

- Africa

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into

- Diagnostic Radioisotopes

- Therapeutic Radioisotopes

Split by applications, this report focuses on sales, market share and growth rate of Radiopharmaceutical in each application, can be divided into

- Oncology

- Cardiology

- Other

This report is available at 12% Discount for Single User License and 15% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

2017-2022 Global Top Countries Radiopharmaceutical Market Report

Table of Contents

2017-2022 Global Top Countries Radiopharmaceutical Market Report
1 Radiopharmaceutical Market Overview
1.1 Product Overview and Scope of Radiopharmaceutical
1.2 Radiopharmaceutical Segment by Types
1.2.1 Global Sales Market Share of Radiopharmaceutical by Types in 2016
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Radiopharmaceutical Segment by Applications
1.3.1 Radiopharmaceutical Consumption Market Share by Applications in 2016
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Radiopharmaceutical Market by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Canada Status and Prospect (2012-2022)
1.4.3 Germany Status and Prospect (2012-2022)
1.4.4 France Status and Prospect (2012-2022)
1.4.5 UK Status and Prospect (2012-2022)
1.4.6 Italy Status and Prospect (2012-2022)
1.4.7 Russia Status and Prospect (2012-2022)
1.4.8 China Status and Prospect (2012-2022)
1.4.9 Japan Status and Prospect (2012-2022)
1.4.10 India Status and Prospect (2012-2022)
1.4.11 Korea Status and Prospect (2012-2022)
1.4.12 Southeast Asia Status and Prospect (2012-2022)
1.4.13 Australia Status and Prospect (2012-2022)
1.4.14 Brazil Status and Prospect (2012-2022)
1.4.15 Mexico Status and Prospect (2012-2022)
1.4.16 Middle East Status and Prospect (2012-2022)
1.4.17 Africa Status and Prospect (2012-2022)
1.5 Global Radiopharmaceutical Overview and Market Size (Value) (2012-2022)
1.5.1 Global Market Radiopharmaceutical Overview
1.5.2 Global Market Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
2 Global Radiopharmaceutical Sales, Revenue (Value) and Market Share by Manufacturers
2.1 Global Radiopharmaceutical Sales and Market Share in 2016 and 2017 by Manufacturers
2.1.1 Global Radiopharmaceutical Sales by Manufacturers in 2016 and 2017
2.1.2 Global Radiopharmaceutical Sales Market Share (%) by Manufacturers in 2016 and 2017
2.2 Global Radiopharmaceutical Revenue and Market Share by Manufacturers in 2016 and 2017
2.2.1 Global Radiopharmaceutical Revenue by Manufacturers in 2016 and 2017
2.2.2 Global Radiopharmaceutical Revenue Market Share (%) by Manufacturers in 2016 and 2017
2.3 Global Radiopharmaceutical Average Price by Manufacturers in 2016 and 2017
2.4 Global Radiopharmaceutical Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
2.4.1 Global Radiopharmaceutical Manufacturing Base Distribution and Sales Area by Manufacturers
2.4.2 Manufacturers Radiopharmaceutical Product Types
2.5 Radiopharmaceutical Market Competitive Situation and Trends
2.5.1 Radiopharmaceutical Market Concentration Rate
2.5.2 Radiopharmaceutical Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Radiopharmaceutical Sales, Revenue (Value) by Countries, Type and Application (2012-2017)
3.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Countries (2012-2017)
3.1.1 Global Radiopharmaceutical Sales and Market Share by Countries (2012-2017)
3.1.2 Global Radiopharmaceutical Revenue and Market Share by Countries (2012-2017)
3.1.3 Global Radiopharmaceutical Price by Countries (2012-2017)
3.2 Global Radiopharmaceutical Sales, Revenue, Market Share and Price by Type (2012-2017)
3.2.1 Global Radiopharmaceutical Sales and Market Share by Type (2012-2017)
3.2.2 Global Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
3.2.3 Global Radiopharmaceutical Price by Type (2012-2017)
3.3 Global Radiopharmaceutical Sales and Market Share by Application (2012-2017)
3.3.1 Global Radiopharmaceutical Sales by Application (2012-2017)
3.3.2 Global Radiopharmaceutical Sales and Market Share by Application (2012-2017)
3.4 Global Market Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4 Global Radiopharmaceutical Manufacturers Profiles/Analysis
4.1 Bayer
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Radiopharmaceutical Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.2 Triad Isotopes
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Radiopharmaceutical Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.3 Lantheus
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Radiopharmaceutical Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.4 GE Healthcare
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Radiopharmaceutical Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.5 Mallinckrodt
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Radiopharmaceutical Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.6 Eli Lilly
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Radiopharmaceutical Product Types, Application and Specification
4.6.2.1 Type 1
4.6.2.2 Type 2
4.6.3 Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.7 Bracco Imaging
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Radiopharmaceutical Product Types, Application and Specification
4.7.2.1 Type 1
4.7.2.2 Type 2
4.7.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.8 SIEMENS
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Radiopharmaceutical Product Types, Application and Specification
4.8.2.1 Type 1
4.8.2.2 Type 2
4.8.3 SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.9 Navidea
4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.9.2 Radiopharmaceutical Product Types, Application and Specification
9.9.2.1 Type 1
9.9.2.2 Type 2
4.9.3 Navidea Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.9.4 Main Business/Business Overview
4.10 Nordion
4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.10.2 Radiopharmaceutical Product Types, Application and Specification
4.10.2.1 Type 1
4.10.2.2 Type 2
4.10.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.10.4 Main Business/Business Overview
4.11 IBA Group
4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.11.2 Radiopharmaceutical Product Types, Application and Specification
4.11.2.1 Type 1
4.11.2.2 Type 2
4.11.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.11.4 Main Business/Business Overview
4.12 Jubilant Pharma
4.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.12.2 Radiopharmaceutical Product Types, Application and Specification
4.12.2.1 Type 1
4.12.2.2 Type 2
4.12.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
4.12.4 Main Business/Business Overview
5 North America Radiopharmaceutical Sales, Revenue (Value) by Countries, Type and Application (2012-2017)
5.1 North America Radiopharmaceutical Sales, Revenue and Market Share by Countries (2012-2017)
5.1.1 North America Radiopharmaceutical Sales and Market Share by Countries (2012-2017)
5.1.2 North America Radiopharmaceutical Revenue and Market Share by Countries (2012-2017)
5.1.3 North America Radiopharmaceutical Price by Countries (2012-2017)
5.1.4 North America Market Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
5.1.5 North America Radiopharmaceutical Import & Export (2012-2017)
5.2 United States Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
5.2.1 United States Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
5.2.2 United States Radiopharmaceutical Sales and Market Share by Type (2012-2017)
5.2.3 United States Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
5.2.4 United States Radiopharmaceutical Price by Type (2012-2017)
5.2.5 United States Radiopharmaceutical Sales and Market Share by Application (2012-2017)
5.3 Canada Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
5.3.1 Canada Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
5.3.2 Canada Radiopharmaceutical Sales and Market Share by Type (2012-2017)
5.3.3 Canada Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
5.3.4 Canada Radiopharmaceutical Price by Type (2012-2017)
5.3.5 Canada Radiopharmaceutical Sales and Market Share by Application (2012-2017)
6 Latin America Radiopharmaceutical Sales, Revenue (Value) by Countries, Type and Application (2012-2017)
6.1 Latin America Radiopharmaceutical Sales, Revenue and Market Share by Countries (2012-2017)
6.1.1 Latin America Radiopharmaceutical Sales and Market Share by Countries (2012-2017)
6.1.2 Latin America Radiopharmaceutical Revenue and Market Share by Countries (2012-2017)
6.1.3 Latin America Radiopharmaceutical Price by Countries (2012-2017)
6.1.4 Latin America Market Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.5 Latin America Radiopharmaceutical Import & Export (2012-2017)
6.2 Mexico Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
6.2.1 Mexico Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
6.2.2 Mexico Radiopharmaceutical Sales and Market Share by Type (2012-2017)
6.2.3 Mexico Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
6.2.4 Mexico Radiopharmaceutical Price by Type (2012-2017)
6.2.5 Mexico Radiopharmaceutical Sales and Market Share by Application (2012-2017)
6.3 Brazil Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
6.3.1 Brazil Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
6.3.2 Brazil Radiopharmaceutical Sales and Market Share by Type (2012-2017)
6.3.3 Brazil Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
6.3.4 Brazil Radiopharmaceutical Price by Type (2012-2017)
6.3.5 Brazil Radiopharmaceutical Sales and Market Share by Application (2012-2017)
7 Europe Radiopharmaceutical Sales, Revenue (Value) by Countries, Type and Application (2012-2017)
7.1 Europe Radiopharmaceutical Sales, Revenue and Market Share by Countries (2012-2017)
7.1.1 Europe Radiopharmaceutical Sales and Market Share by Countries (2012-2017)
7.1.2 Europe Radiopharmaceutical Revenue and Market Share by Countries (2012-2017)
7.1.3 Europe Radiopharmaceutical Price by Countries (2012-2017)
7.1.4 Europe Market Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
7.1.5 Europe Radiopharmaceutical Import & Export (2012-2017)
7.2 Germany Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
7.2.1 Germany Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
7.2.2 Germany Radiopharmaceutical Sales and Market Share by Type (2012-2017)
7.2.3 Germany Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
7.2.4 Germany Radiopharmaceutical Price by Type (2012-2017)
7.2.5 Germany Radiopharmaceutical Sales and Market Share by Application (2012-2017)
7.3 France Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
7.3.1 France Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
7.3.2 France Radiopharmaceutical Sales and Market Share by Type (2012-2017)
7.3.3 France Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
7.3.4 France Radiopharmaceutical Price by Type (2012-2017)
7.3.5 France Radiopharmaceutical Sales and Market Share by Application (2012-2017)
7.4 UK Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
7.4.1 UK Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
7.4.2 UK Radiopharmaceutical Sales and Market Share by Type (2012-2017)
7.4.3 UK Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
7.4.4 UK Radiopharmaceutical Price by Type (2012-2017)
7.4.5 UK Radiopharmaceutical Sales and Market Share by Application (2012-2017)
7.5 Italy Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
7.5.1 Italy Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
7.5.2 Italy Radiopharmaceutical Sales and Market Share by Type (2012-2017)
7.5.3 Italy Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
7.5.4 Italy Radiopharmaceutical Price by Type (2012-2017)
7.5.5 Italy Radiopharmaceutical Sales and Market Share by Application (2012-2017)
7.6 Russia Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
7.6.1 Russia Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
7.6.2 Russia Radiopharmaceutical Sales and Market Share by Type (2012-2017)
7.6.3 Russia Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
7.6.4 Russia Radiopharmaceutical Price by Type (2012-2017)
7.6.5 Russia Radiopharmaceutical Sales and Market Share by Application (2012-2017)
8 Asia-Pacific Radiopharmaceutical Sales, Revenue (Value) by Countries, Type and Application (2012-2017)
8.1 Asia-Pacific Radiopharmaceutical Sales, Revenue and Market Share by Countries (2012-2017)
8.1.1 Asia-Pacific Radiopharmaceutical Sales and Market Share by Countries (2012-2017)
8.1.2 Asia-Pacific Radiopharmaceutical Revenue and Market Share by Countries (2012-2017)
8.1.3 Asia-Pacific Radiopharmaceutical Price by Countries (2012-2017)
8.1.4 Asia-Pacific Market Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
8.1.5 Asia-Pacific Radiopharmaceutical Import & Export (2012-2017)
8.2 China Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
8.2.1 China Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
8.2.2 China Radiopharmaceutical Sales and Market Share by Type (2012-2017)
8.2.3 China Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
8.2.4 China Radiopharmaceutical Price by Type (2012-2017)
8.2.5 China Radiopharmaceutical Sales and Market Share by Application (2012-2017)
8.3 Japan Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
8.3.1 Japan Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
8.3.2 Japan Radiopharmaceutical Sales and Market Share by Type (2012-2017)
8.3.3 Japan Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
8.3.4 Japan Radiopharmaceutical Price by Type (2012-2017)
8.3.5 Japan Radiopharmaceutical Sales and Market Share by Application (2012-2017)
8.4 Korea Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
8.4.1 Korea Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
8.4.2 Korea Radiopharmaceutical Sales and Market Share by Type (2012-2017)
8.4.3 Korea Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
8.4.4 Korea Radiopharmaceutical Price by Type (2012-2017)
8.4.5 Korea Radiopharmaceutical Sales and Market Share by Application (2012-2017)
8.5 India Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
8.5.1 India Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
8.5.2 India Radiopharmaceutical Sales and Market Share by Type (2012-2017)
8.5.3 India Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
8.5.4 India Radiopharmaceutical Price by Type (2012-2017)
8.5.5 India Radiopharmaceutical Sales and Market Share by Application (2012-2017)
8.6 Southeast Asia Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
8.6.1 Southeast Asia Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
8.6.2 Southeast Asia Radiopharmaceutical Sales and Market Share by Type (2012-2017)
8.6.3 Southeast Asia Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
8.6.4 Southeast Asia Radiopharmaceutical Price by Type (2012-2017)
8.6.5 Southeast Asia Radiopharmaceutical Sales and Market Share by Application (2012-2017)
9 Middle East and Africa Radiopharmaceutical Sales, Revenue (Value) by Countries, Type and Application (2012-2017)
9.1 Middle East and Africa Radiopharmaceutical Sales, Revenue and Market Share by Countries (2012-2017)
9.1.1 Middle East and Africa Radiopharmaceutical Sales and Market Share by Countries (2012-2017)
9.1.2 Middle East and Africa Radiopharmaceutical Revenue and Market Share by Countries (2012-2017)
9.1.3 Middle East and Africa Radiopharmaceutical Price by Countries (2012-2017)
9.1.4 Middle East and Africa Market Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
9.2 Middle East Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
9.2.1 Middle East Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
9.2.2 Middle East Radiopharmaceutical Sales and Market Share by Type (2012-2017)
9.2.3 Middle East Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
9.2.4 Middle East Radiopharmaceutical Price by Type (2012-2017)
9.2.5 Middle East Radiopharmaceutical Sales and Market Share by Application (2012-2017)
9.3 Africa Radiopharmaceutical Sales, Revenue and Growth, by Type and Application (2012-2017)
9.3.1 Africa Radiopharmaceutical Sales, Revenue and Growth Rate (2012-2017)
9.3.2 Africa Radiopharmaceutical Sales and Market Share by Type (2012-2017)
9.3.3 Africa Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
9.3.4 Africa Radiopharmaceutical Price by Type (2012-2017)
9.3.5 Africa Radiopharmaceutical Sales and Market Share by Application (2012-2017)
10 Radiopharmaceutical Manufacturing Cost Analysis
10.1 Radiopharmaceutical Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Expenses
10.3 Manufacturing Process Analysis of Radiopharmaceutical
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Radiopharmaceutical Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Radiopharmaceutical Major Manufacturers in 2016
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Radiopharmaceutical Market Forecast (2017-2022)
14.1 Global Radiopharmaceutical Sales, Revenue Forecast (2017-2022)
14.2 Global Radiopharmaceutical Sales, Consumption Forecast by Countries (2017-2022)
14.2.1 Global Radiopharmaceutical Sales Forecast by Countries (2017-2022)
14.2.2 Global Radiopharmaceutical Sales Market Share Forecast by Countries (2017-2022)
14.3 Global Radiopharmaceutical Sales and Market Share Forecast by Type (2017-2022)
14.3.1 Global Radiopharmaceutical Sales Forecast by Type (2017-2022)
14.3.2 Global Radiopharmaceutical Sales Market Share Forecast by Type (2017-2022)
14.4 Global Radiopharmaceutical Sales and Market Share Forecast by Application (2017-2022)
14.4.1 Global Radiopharmaceutical Sales Forecast by Application (2017-2022)
14.4.2 Global Radiopharmaceutical Sales Market Share Forecast by Application (2017-2022)
14.5 Radiopharmaceutical Price Forecast (2017-2022)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Data Source

List of Tables and Figures

Figure Picture of Radiopharmaceutical
Table Product Specifications of Radiopharmaceutical
Figure Global Sales Market Share of Radiopharmaceutical by Types in 2016
Table Types of Radiopharmaceutical
Figure Product Picture of Diagnostic Radioisotopes
Table Major Players of Diagnostic Radioisotopes
Figure Product Picture of Therapeutic Radioisotopes
Table Major Players of Therapeutic Radioisotopes
Figure Radiopharmaceutical Consumption Market Share by Applications in 2016
Table Applications of Radiopharmaceutical
Figure Oncology Examples
Figure Cardiology Examples
Figure Other Examples
Figure United States Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Germany Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure France Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure UK Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Italy Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Russia Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Korea Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Brazil Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Radiopharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
Table Global Radiopharmaceutical Sales by Manufacturers in 2016 and 2017
Table Global Radiopharmaceutical Sales Market Share (%) by Manufacturers in 2016 and 2017
Figure Global Radiopharmaceutical Sales Share by Manufacturers in 2016
Figure Global Radiopharmaceutical Sales Share by Manufacturers in 2017
Table Global Radiopharmaceutical Revenue by Manufacturers in 2016 and 2017
Table Global Radiopharmaceutical Revenue Market Share (%) by Manufacturers in 2016 and 2017
Figure Global Radiopharmaceutical Revenue Share by Manufacturers in 2016
Figure Global Radiopharmaceutical Revenue Share by Manufacturers in 2017
Table Global Radiopharmaceutical Average Price by Manufacturers in 2016 and 2017
Figure Global Radiopharmaceutical Average Price by Manufacturers in 2016
Table Global Radiopharmaceutical Manufacturing Base Distribution and Sales Area by Manufacturers
Table Manufacturers Radiopharmaceutical Product Types
Figure Radiopharmaceutical Market Share of Top 3 Manufacturers
Figure Radiopharmaceutical Market Share of Top 5 Manufacturers
Table Global Radiopharmaceutical Sales by Countries (2012-2017)
Table Global Radiopharmaceutical Sales and Market Share by Countries (2012-2017)
Figure Global Radiopharmaceutical Sales Market Share by Countries (2012)
Figure Global Radiopharmaceutical Sales Market Share by Countries (2016)
Table Global Radiopharmaceutical Revenue by Countries (2012-2017)
Table Global Radiopharmaceutical Revenue and Market Share by Countries (2012-2017)
Figure 2012 Global Radiopharmaceutical Revenue Market Share by Countries
Figure 2016 Global Radiopharmaceutical Revenue Market Share by Countries
Table Global Radiopharmaceutical Price by Countries (2012-2017)
Table Global Radiopharmaceutical Sales by Type (2012-2017)
Table Global Radiopharmaceutical Sales and Market Share by Type (2012-2017)
Figure Global Radiopharmaceutical Sales Market Share by Type (2012-2017)
Figure 2016 Global Radiopharmaceutical Sales Market Share by Type
Table Global Radiopharmaceutical Revenue by Type (2012-2017)
Table Global Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
Figure Global Radiopharmaceutical Revenue Market Share by Type (2012-2017)
Figure 2016 Global Radiopharmaceutical Revenue Market Share by Type
Table Global Radiopharmaceutical Price by Type (2012-2017)
Table Global Radiopharmaceutical Sales by Application (2012-2017)
Figure 2016 Global Radiopharmaceutical Sales Market Share by Application
Table Global Radiopharmaceutical Sales and Market Share by Application (2012-2017)
Figure Global Radiopharmaceutical Sales Market Share by Application (2012-2017)
Table Global Market Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Radiopharmaceutical Market Share (2012-2017)
Table Triad Isotopes Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Triad Isotopes Radiopharmaceutical Market Share (2012-2017)
Table Lantheus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lantheus Radiopharmaceutical Market Share (2012-2017)
Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GE Healthcare Radiopharmaceutical Market Share (2012-2017)
Table Mallinckrodt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mallinckrodt Radiopharmaceutical Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Radiopharmaceutical Market Share (2012-2017)
Table Bracco Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bracco Imaging Radiopharmaceutical Market Share (2012-2017)
Table SIEMENS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure SIEMENS Radiopharmaceutical Market Share (2012-2017)
Table Navidea Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Navidea Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Navidea Radiopharmaceutical Market Share (2012-2017)
Table Nordion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Nordion Radiopharmaceutical Market Share (2012-2017)
Table IBA Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure IBA Group Radiopharmaceutical Market Share (2012-2017)
Table Jubilant Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Jubilant Pharma Radiopharmaceutical Market Share (2012-2017)
Table North America Radiopharmaceutical Sales by Countries (2012-2017)
Table North America Radiopharmaceutical Sales and Market Share by Countries (2012-2017)
Figure North America Radiopharmaceutical Sales Market Share by Countries (2012)
Figure North America Radiopharmaceutical Sales Market Share by Countries (2016)
Table North America Radiopharmaceutical Revenue by Countries (2012-2017)
Table North America Radiopharmaceutical Revenue and Market Share by Countries (2012-2017)
Figure 2012 North America Radiopharmaceutical Revenue Market Share by Countries
Figure 2016 North America Radiopharmaceutical Revenue Market Share by Countries
Table North America Radiopharmaceutical Price by Countries (2012-2017)
Table North America Market Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
Table North America Radiopharmaceutical Import & Export (2012-2017)
Figure United States Radiopharmaceutical Sales and Growth Rate (2012-2017)
Figure United States Radiopharmaceutical Revenue and Growth Rate (2012-2017)
Table United States Radiopharmaceutical Sales by Type (2012-2017)
Table United States Radiopharmaceutical Sales and Market Share by Type (2012-2017)
Figure United States Radiopharmaceutical Sales Market Share by Type (2012-2017)
Figure 2016 United States Radiopharmaceutical Sales Market Share by Type
Table United States Radiopharmaceutical Revenue by Type (2012-2017)
Table United States Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
Figure United States Radiopharmaceutical Revenue Market Share by Type (2012-2017)
Figure 2016 United States Radiopharmaceutical Revenue Market Share by Type
Table United States Radiopharmaceutical Price by Type (2012-2017)
Table United States Radiopharmaceutical Sales by Application (2012-2017)
Table United States Radiopharmaceutical Sales
  • Global Radiation Dose Management Market Professional Survey Report 2017
    Published: 09-Nov-2017        Price: US 3500 Onwards        Pages: 110
    This report studies Radiation Dose Management in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Bayer AG - GE Healthcare - PACSHealth LLC - Philips N.V.......
  • North America Radiopharmaceutical Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 27-Oct-2017        Price: US 4480 Onwards        Pages: 124
    Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for ex......
  • United States Radiation Dose Management Market Report 2017
    Published: 18-Oct-2017        Price: US 3800 Onwards        Pages: 107
    In this report, the United States Radiation Dose Management market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growt......
  • Global Radiation Dose Management Sales Market Report 2017
    Published: 16-Oct-2017        Price: US 4000 Onwards        Pages: 114
    In this report, the global Radiation Dose Management market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Radiation Dose Management for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global Radiation Dose Management Market Research Report 2017
    Published: 04-Oct-2017        Price: US 2900 Onwards        Pages: 118
    In this report, the global Radiation Dose Management market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Radiation Dose Management in these regions, from 2012 to 2022 (forecast), covering - North America - Europe ......
  • Global and Regional Radiopharmaceutical Market Research Report 2017
    Published: 28-Sep-2017        Price: US 3500 Onwards        Pages: 131
    Summary Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy fo......
  • Global Radiopharmaceutical Market Data Survey Report 2025
    Published: 26-Sep-2017        Price: US 1500 Onwards        Pages: 86
    Summary Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy fo......
  • 2017 Top 5 Radiopharmaceutical Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 13-Sep-2017        Price: US 4960 Onwards        Pages: 151
    "This report will be delivered in 2-3 business days after the order is placed." The Global Radiopharmaceutical market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Radiopharmaceutical in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Radiopharmaceutical Players......
  • 2017-2022 China Radiopharmaceutical Market Report (Status and Outlook)
    Published: 13-Sep-2017        Price: US 3360 Onwards        Pages: 110
    "This report will be delivered in 2-3 business days after the order is placed." The Radiopharmaceutical market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include - Bayer - Triad Isotopes - Lantheus - GE Healthcare - Mallinckrodt - Eli Lilly - Bracco Imaging -......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs